SLC39A14 and glioma: Moreover, in both erastin-treated glioma cells, SLC39A14 knockdown significantly enhanced the concentration of MDA, Fe2+ and significantly reduced the levels of GSH (Fig. 6B-D).Ferroptosis is characterized by a distinctive mechanism involving GSH depletion and the accumulation of lipid ROS [7].